Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Peptic Ulcer

  Free Subscription


Articles published in J Gastroenterol

Retrieve available abstracts of 36 articles:
HTML format



Single Articles


    June 2021
  1. MATSUHASHI T, Hatta W, Hikichi T, Fukuda S, et al
    A simple prediction score for in-hospital mortality in patients with nonvariceal upper gastrointestinal bleeding.
    J Gastroenterol. 2021 Jun 18. pii: 10.1007/s00535-021-01797.
    PubMed     Abstract available


    February 2021
  2. KAMADA T, Satoh K, Itoh T, Ito M, et al
    Evidence-based clinical practice guidelines for peptic ulcer disease 2020.
    J Gastroenterol. 2021 Feb 23. pii: 10.1007/s00535-021-01769.
    PubMed     Abstract available


  3. LAI SW
    Proton pump inhibitors and the risk of pancreatic cancer.
    J Gastroenterol. 2021 Feb 5. pii: 10.1007/s00535-021-01764.
    PubMed    


  4. BRUSSELAERS N, Sadr-Azodi O, Engstrand L
    Proton pump inhibitors and the risk of pancreatic cancer.
    J Gastroenterol. 2021 Feb 2. pii: 10.1007/s00535-021-01761.
    PubMed    


    November 2020
  5. IBANEZ-SANZ G, Mila N, de la Pena-Negro LC, Garcia M, et al
    Proton-pump inhibitors are associated with a high false-positivity rate in faecal immunochemical testing.
    J Gastroenterol. 2020 Nov 7. pii: 10.1007/s00535-020-01738.
    PubMed     Abstract available


  6. ROGERS B, Samanta S, Ghobadi K, Patel A, et al
    Artificial intelligence automates and augments baseline impedance measurements from pH-impedance studies in gastroesophageal reflux disease.
    J Gastroenterol. 2020 Nov 5. pii: 10.1007/s00535-020-01743.
    PubMed     Abstract available


    September 2020
  7. OKUBO H, Akiyama J, Kobayakawa M, Kawazoe M, et al
    Vonoprazan-based triple therapy is effective for Helicobacter pylori eradication irrespective of clarithromycin susceptibility.
    J Gastroenterol. 2020 Sep 15. pii: 10.1007/s00535-020-01723.
    PubMed     Abstract available


    August 2020
  8. SAWADA A, Itami H, Nakagawa K, Hirano S, et al
    Supragastric belching in Japan: lower prevalence and relevance for management of gastroesophageal reflux disease compared to United Kingdom.
    J Gastroenterol. 2020 Aug 24. pii: 10.1007/s00535-020-01720.
    PubMed     Abstract available


    April 2020
  9. MASUDA K, Urabe Y, Ito M, Ono A, et al
    Correction to: Genomic landscape of epithelium with low-grade atypia on gastric cancer after Helicobacter pylori eradication therapy.
    J Gastroenterol. 2020 Apr 19. pii: 10.1007/s00535-020-01688.
    PubMed     Abstract available


    February 2020
  10. SUGIMOTO M, Murata M, Kawai T
    How long should patients be surveyed for gastric cancer risk after Helicobacter pylori eradication therapy? 10 years is no longer enough.
    J Gastroenterol. 2020 Feb 5. pii: 10.1007/s00535-020-01674.
    PubMed    


    January 2020
  11. OSHIMA T, Wu L, Li M, Fukui H, et al
    Correction to: Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.
    J Gastroenterol. 2020 Jan 30. pii: 10.1007/s00535-020-01671.
    PubMed     Abstract available


    December 2019
  12. TAKE S, Mizuno M, Ishiki K, Kusumoto C, et al
    Correction to: Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication.
    J Gastroenterol. 2019 Dec 9. pii: 10.1007/s00535-019-01654.
    PubMed     Abstract available


  13. BRUSSELAERS N, Sadr-Azodi O, Engstrand L
    Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden.
    J Gastroenterol. 2019 Dec 6. pii: 10.1007/s00535-019-01652.
    PubMed     Abstract available


    October 2019
  14. TAKE S, Mizuno M, Ishiki K, Kusumoto C, et al
    Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication.
    J Gastroenterol. 2019 Oct 30. pii: 10.1007/s00535-019-01639.
    PubMed     Abstract available


    August 2019
  15. YOKOYA Y, Igarashi A, Uda A, Deguchi H, et al
    Cost-utility analysis of a 'vonoprazan-first' strategy versus 'esomeprazole- or rabeprazole-first' strategy in GERD.
    J Gastroenterol. 2019 Aug 8. pii: 10.1007/s00535-019-01609.
    PubMed     Abstract available


    June 2019
  16. MASUDA K, Urabe Y, Ito M, Ono A, et al
    Genomic landscape of epithelium with low-grade atypia on gastric cancer after Helicobacter pylori eradiation therapy.
    J Gastroenterol. 2019 Jun 13. pii: 10.1007/s00535-019-01596.
    PubMed     Abstract available


  17. PARK YH, Seong JM, Cho S, Han HW, et al
    Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study.
    J Gastroenterol. 2019 Jun 11. pii: 10.1007/s00535-019-01598.
    PubMed     Abstract available


    May 2019
  18. ANSARI S, Akada J, Matsuo Y, Shiota S, et al
    Epitope peptides of Helicobacter pylori CagA antibodies from sera by whole-peptide mapping.
    J Gastroenterol. 2019 May 2. pii: 10.1007/s00535-019-01584.
    PubMed     Abstract available


    April 2019
  19. TAKEUCHI T, Hongo H, Kimura T, Kojima Y, et al
    Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors : Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study.
    J Gastroenterol. 2019 Apr 29. pii: 10.1007/s00535-019-01588.
    PubMed     Abstract available


  20. SUGAWARA K, Koizumi S, Horikawa Y, Mimori N, et al
    Is the new potent acid-inhibitory drug vonoprazan effective for healing idiopathic peptic ulcers? A multicenter observational study in Akita Prefecture, Japan.
    J Gastroenterol. 2019 Apr 29. pii: 10.1007/s00535-019-01587.
    PubMed     Abstract available


    March 2019
  21. MIWA H, Igarashi A, Teng L, Uda A, et al
    Systematic review with network meta-analysis: indirect comparison of the efficacy of vonoprazan and proton-pump inhibitors for maintenance treatment of gastroesophageal reflux disease.
    J Gastroenterol. 2019 Mar 27. pii: 10.1007/s00535-019-01572.
    PubMed     Abstract available


  22. ISSHI K, Matsuhashi N, Joh T, Higuchi K, et al
    Correction to: Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study.
    J Gastroenterol. 2019 Mar 11. pii: 10.1007/s00535-019-01557.
    PubMed     Abstract available


    February 2019
  23. KAKIUCHI T, Matsuo M, Endo H, Nakayama A, et al
    A Helicobacter pylori screening and treatment program to eliminate gastric cancer among junior high school students in Saga Prefecture: a preliminary report.
    J Gastroenterol. 2019 Feb 15. pii: 10.1007/s00535-019-01559.
    PubMed     Abstract available


    January 2019
  24. ISSHI K, Matsuhashi N, Joh T, Higuchi K, et al
    Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study.
    J Gastroenterol. 2019 Jan 23. pii: 10.1007/s00535-019-01546.
    PubMed     Abstract available


    September 2018
  25. XIAO S, Li S, Zhou L, Jiang W, et al
    Helicobacter pylori status and risks of metachronous recurrence after endoscopic resection of early gastric cancer: a systematic review and meta-analysis.
    J Gastroenterol. 2018 Sep 24. pii: 10.1007/s00535-018-1513.
    PubMed     Abstract available


    June 2018
  26. HAMADA K, Uedo N, Tonai Y, Arao M, et al
    Efficacy of vonoprazan in prevention of bleeding from endoscopic submucosal dissection-induced gastric ulcers: a prospective randomized phase II study.
    J Gastroenterol. 2018 Jun 25. pii: 10.1007/s00535-018-1487.
    PubMed     Abstract available


    March 2018
  27. PONZETTO A, Figura N
    Gastric cancer prevention and Helicobacter pylori.
    J Gastroenterol. 2018 Mar 29. pii: 10.1007/s00535-018-1453.
    PubMed    


    November 2017
  28. KINOSHITA Y, Kato M, Fujishiro M, Masuyama H, et al
    Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study.
    J Gastroenterol. 2017 Nov 29. pii: 10.1007/s00535-017-1417.
    PubMed     Abstract available


  29. KUSANO C, Gotoda T, Suzuki S, Ikehara H, et al
    Safety of first-line triple therapy with a potassium-competitive acid blocker for Helicobacter pylori eradication in children.
    J Gastroenterol. 2017 Nov 7. doi: 10.1007/s00535-017-1406.
    PubMed     Abstract available


    September 2017
  30. IMPERATORE N, Tortora R, Testa A, Gerbino N, et al
    Erratum to: Proton pump inhibitors as risk factor for metabolic syndrome and hepatic steatosis in coeliac disease patients on gluten-free diet.
    J Gastroenterol. 2017 Sep 19. doi: 10.1007/s00535-017-1393.
    PubMed     Abstract available


    August 2017
  31. IMPERATORE N, Tortora R, Anna T, Gerbino N, et al
    Proton pump inhibitors as risk factor for metabolic syndrome and hepatic steatosis in coeliac disease patients on gluten-free diet.
    J Gastroenterol. 2017 Aug 19. doi: 10.1007/s00535-017-1381.
    PubMed     Abstract available


  32. SU T, Lai S, Lee A, He X, et al
    Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth.
    J Gastroenterol. 2017 Aug 2. doi: 10.1007/s00535-017-1371.
    PubMed     Abstract available


    July 2017
  33. OSHIMA T, Wu L, Li M, Fukui H, et al
    Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.
    J Gastroenterol. 2017 Jul 25. doi: 10.1007/s00535-017-1369.
    PubMed     Abstract available


    April 2017
  34. KIM TJ, Sinn DH, Min YW, Son HJ, et al
    A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease.
    J Gastroenterol. 2017 Apr 5. doi: 10.1007/s00535-017-1337.
    PubMed     Abstract available


    February 2017
  35. KUSANO M, Hosaka H, Yasuoka H, Kawamura O, et al
    New endoscopic classification of cascade stomach, a risk factor for reflux esophagitis.
    J Gastroenterol. 2017;52:211-217.
    PubMed     Abstract available


    January 2017
  36. HORIUCHI Y, Fujisaki J, Yamamoto N, Omae M, et al
    Diagnostic accuracy of demarcation of undifferentiated-type early gastric cancer after Helicobacter pylori eradication.
    J Gastroenterol. 2017 Jan 12. doi: 10.1007/s00535-017-1307.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Peptic Ulcer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: